Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Xiao-Hua Yu, Jing Zhao, Shu-Cheng Zhang, Jian-Hui Li, Jun-Biao Zheng, Zheng Li, Guo-Qing Liang, Hui-Juan Shi, Wei-Jin Zhou & Qian-Xi Zhu. (2017) The impact of age, BMI and sex hormone on aging males’ symptoms and the international index of erectile function scores. The Aging Male 20:4, pages 235-240.
Read now
Read now
Amanda Rao, Elizabeth Steels, Warrick J. Inder, Suzanne Abraham & Luis Vitetta. (2016) Testofen, a specialised Trigonella foenum-graecum seed extract reduces age-related symptoms of androgen decrease, increases testosterone levels and improves sexual function in healthy aging males in a double-blind randomised clinical study. The Aging Male 19:2, pages 134-142.
Read now
Read now
Articles from other publishers (35)
Filippo Maria Nimbi & Chiara Simonelli. (2022) The Sex Therapists’ Approach to the Evaluation and Management of Low Sex Drive in Men. The Journal of Sexual Medicine 19:4, pages 546-552.
Crossref
Crossref
CL Wood, J Page, J Foggin, M Guglieri, V Straub & TD Cheetham. (2021) The impact of testosterone therapy on quality of life in adolescents with Duchenne muscular dystrophy. Neuromuscular Disorders 31:12, pages 1259-1265.
Crossref
Crossref
Karlijn Pellikaan, Yassine Ben Brahim, Anna G. W. Rosenberg, Kirsten Davidse, Christine Poitou, Muriel Coupaye, Anthony P. Goldstone, Charlotte Høybye, Tania P. Markovic, Graziano Grugni, Antonino Crinò, Assumpta Caixàs, Talia Eldar-Geva, Harry J. Hirsch, Varda Gross-Tsur, Merlin G. Butler, Jennifer L. Miller, Sjoerd A. A. van den Berg, Aart J. van der Lely & Laura C. G. de Graaff. (2021) Hypogonadism in Adult Males with Prader-Willi Syndrome—Clinical Recommendations Based on a Dutch Cohort Study, Review of the Literature and an International Expert Panel Discussion. Journal of Clinical Medicine 10:19, pages 4361.
Crossref
Crossref
Craig R. Jenkins, Alex Rittel, Rodney X. Sturdivant, Jen Wan, Philip G. Clerc, Evan Manning, Lydia M. Jenkins, Jana L. Wardian & Sky D. Graybill. (2021) Glycemic benefits with adherence to testosterone therapy in men with hypogonadism and type 2 diabetes mellitus. Andrology 9:4, pages 1076-1085.
Crossref
Crossref
Sasikala M. Chinnappan, Annie George, Pragya Pandey, Govinda Narke & Yogendra Kumar Choudhary. (2021) Effect of Eurycoma longifolia standardised aqueous root extract–Physta® on testosterone levels and quality of life in ageing male subjects: a randomised, double-blind, placebo-controlled multicentre study. Food & Nutrition Research 65.
Crossref
Crossref
Beatrice A Golomb & Brinton K Berg. (2021) Chocolate Consumption and Sex-Interest. Cureus.
Crossref
Crossref
Donald Pfaff & Farid Saad. (2020) Sexual motivation: problem solved and new problems introduced. Hormone Molecular Biology and Clinical Investigation 41:2.
Crossref
Crossref
Filippo Maria Nimbi, Francesca Tripodi, Roberta Rossi, Felipe Navarro-Cremades & Chiara Simonelli. (2020) Male Sexual Desire: An Overview of Biological, Psychological, Sexual, Relational, and Cultural Factors Influencing Desire. Sexual Medicine Reviews 8:1, pages 59-91.
Crossref
Crossref
C. L. Wood, T. D Cheetham, K. G Hollingsworth, M. Guglieri, Y. Ailins-Sahun, S. Punniyakodi, A. Mayhew & V. Straub. (2019) Observational study of clinical outcomes for testosterone treatment of pubertal delay in Duchenne muscular dystrophy. BMC Pediatrics 19:1.
Crossref
Crossref
Abdulmaged M. Traish & Abraham Morgentaler. 2019. Sex Differences in Cardiovascular Physiology and Pathophysiology. Sex Differences in Cardiovascular Physiology and Pathophysiology
321
354
.
André Tchernof, Dannick Brochu, Ina Maltais‐Payette, Mohamed Fouad Mansour, Geneviève B. Marchand, Anne‐Marie Carreau & Jordanna Kapeluto. 2011. Comprehensive Physiology. Comprehensive Physiology
1253
1290
.
S. Arver, C. Stief, J. de la Rosette, T. H. Jones, A. Neijber & D. Carrara. (2018) A new 2% testosterone gel formulation: a comparison with currently available topical preparations. Andrology 6:3, pages 396-407.
Crossref
Crossref
L. Belkoff, G. Brock, D. Carrara, A. Neijber, M. Ando & J. Mitchel. (2018) Efficacy and safety of testosterone replacement gel for treating hypogonadism in men: Phase III open-label studies. Andrologia 50:1, pages e12801.
Crossref
Crossref
Michael Grabner, Zsolt Hepp, Amit Raval, Fang Tian & Mohit Khera. (2018) Topical Testosterone Therapy Adherence and Outcomes Among Men With Primary or Secondary Hypogonadism. The Journal of Sexual Medicine 15:2, pages 148-158.
Crossref
Crossref
Abdulmaged M. Traish. (2018) Benefits and Health Implications of Testosterone Therapy in Men With Testosterone Deficiency. Sexual Medicine Reviews 6:1, pages 86-105.
Crossref
Crossref
Katya B. Rubinow, Jing H. ChaoDerek Hagman, Mario Kratz, Brian Van YserlooNilesh W. Gaikwad, John K. AmoryStephanie T. Page. (2017) Circulating sex steroids coregulate adipose tissue immune cell populations in healthy men. American Journal of Physiology-Endocrinology and Metabolism 313:5, pages E528-E539.
Crossref
Crossref
X. R. Qing, C. C. Wan, X. J. Shang, H. G. Li, C. L. Xiong, X. X. Zhan, D. S. Mo, H. C. Cai, H. P. Zhang, H. T. Guan, X. B. Kong, Y. P. Chen, T. H. Liu, B. J. Hao & S. Y. Zong. (2017) Relative contributions of testosterone deficiency and metabolism syndrome at the risk of reduced quality of life: A cross-sectional study among Chinese mid-aged and elderly men. Andrologia 49:9, pages e12736.
Crossref
Crossref
Abdulmaged M. Traish, Ahmad Haider, Karim Sultan Haider, Gheorghe Doros & Farid Saad. (2017) Long-Term Testosterone Therapy Improves Cardiometabolic Function and Reduces Risk of Cardiovascular Disease in Men with Hypogonadism. Journal of Cardiovascular Pharmacology and Therapeutics 22:5, pages 414-433.
Crossref
Crossref
Glenn Cunningham, Laurence Belkoff, Gerald Brock, Mitchell Efros, Marc Gittelman, Dario Carrara, Anders Neijber, Masakazu Ando & Jules Mitchel. (2017) Efficacy and Safety of a New Topical Testosterone Replacement Gel Therapy for the Treatment of Male Hypogonadism. Endocrine Practice 23:5, pages 557-565.
Crossref
Crossref
Dimitri C. Cassimatis, Matthew T. Crim & Nanette K. Wenger. (2016) Low Testosterone in Men with Cardiovascular Disease or Risk Factors: To Treat or Not To Treat?. Current Treatment Options in Cardiovascular Medicine 18:12.
Crossref
Crossref
G. Corona, V. A. Giagulli, E. Maseroli, L. Vignozzi, A. Aversa, M. Zitzmann, F. Saad, E. Mannucci & M. Maggi. (2016) Testosterone supplementation and body composition: results from a meta-analysis of observational studies. Journal of Endocrinological Investigation 39:9, pages 967-981.
Crossref
Crossref
M. Efros, D. Carrara & A. Neijber. (2016) The efficacy, bioavailability and safety of a novel hydroalcoholic testosterone gel 2% in hypogonadal men: results from phase II open-label studies. Andrologia 48:6, pages 637-645.
Crossref
Crossref
Giovanni Corona, Vito A Giagulli, Elisa Maseroli, Linda Vignozzi, Antonio Aversa, Michael Zitzmann, Farid Saad, Edoardo Mannucci & Mario Maggi. (2016) THERAPY OF ENDOCRINE DISEASE: Testosterone supplementation and body composition: results from a meta-analysis study. European Journal of Endocrinology 174:3, pages R99-R116.
Crossref
Crossref
Gerald Brock, Darell Heiselman, Mario Maggi, Sae Woong Kim, José M. Rodríguez Vallejo, Hermann M. Behre, John McGettigan, Sherie A. Dowsett, Risa P. Hayes, Jack Knorr, Xiao Ni & Kraig Kinchen. (2016) Effect of Testosterone Solution 2% on Testosterone Concentration, Sex Drive and Energy in Hypogonadal Men: Results of a Placebo Controlled Study. Journal of Urology 195:3, pages 699-705.
Crossref
Crossref
Kenneth J DeLayNora HaneyWayne JG Hellstrom. (2016) Modifying Risk Factors in the Management of Erectile Dysfunction: A Review. The World Journal of Men's Health 34:2, pages 89.
Crossref
Crossref
Abdulmaged Traish. (2016) Testosterone therapy in men with testosterone deficiency: Are we beyond the point of no return?. Investigative and Clinical Urology 57:6, pages 384.
Crossref
Crossref
F Saad, A Yassin, G Doros & A Haider. (2015) Effects of long-term treatment with testosterone on weight and waist size in 411 hypogonadal men with obesity classes I-III: observational data from two registry studies. International Journal of Obesity 40:1, pages 162-170.
Crossref
Crossref
Victoria Holloway & Kevan Wylie. (2015) Sex drive and sexual desire. Current Opinion in Psychiatry 28:6, pages 424-429.
Crossref
Crossref
Abdulmaged M. Traish & Michael Zitzmann. (2015) The complex and multifactorial relationship between testosterone deficiency (TD), obesity and vascular disease. Reviews in Endocrine and Metabolic Disorders 16:3, pages 249-268.
Crossref
Crossref
D. M. Kelly & T. H. Jones. (2015) Testosterone and obesity. Obesity Reviews 16:7, pages 581-606.
Crossref
Crossref
R. Heidari, H. Sajadi, A. Pourmand & G. Pourmand. (2015) Can testosterone level be a good predictor of late-onset hypogonadism?. Andrologia 47:4, pages 433-437.
Crossref
Crossref
Abraham Morgentaler, Martin M. Miner, Monica Caliber, Andre T. Guay, Mohit Khera & Abdulmaged M. Traish. (2015) Testosterone Therapy and Cardiovascular Risk: Advances and Controversies. Mayo Clinic Proceedings 90:2, pages 224-251.
Crossref
Crossref
Abdulmaged M. Traish. (2014) Testosterone and weight loss. Current Opinion in Endocrinology, Diabetes & Obesity 21:5, pages 313-322.
Crossref
Crossref
Abdulmaged M. Traish. (2014) Adverse health effects of testosterone deficiency (TD) in men. Steroids 88, pages 106-116.
Crossref
Crossref
Abdulmaged M. Traish. (2014) Outcomes of testosterone therapy in men with testosterone deficiency (TD): Part II. Steroids 88, pages 117-126.
Crossref
Crossref